Table S3 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol. The value of TG was presented as median (interquartile range). The difference between the two groups was determ
Age,waist circumference, weight and height were presented with mean and SD and tested with T-test.Sex, hyperglycemia, family history and sedentary lifestyle were presented with % and tested with Chi2-
